Research progress of axillary de-escalation management after neoadjuvant chemotherapy for clinical lymph node positive patients

In the era of effective systemic therapy and Anti Theft System precise radiotherapy, neoadjuvant treatment (NAT) for breast cancer can de-escalate breast cancer treatment to conserve breast and spare axillary lymph node dissection (ALND).At present, high axillary nodal pathologic complete response (apCR) is achieved in patients with human epidermal

read more